EV/EBITDA
-16.67
+0.70+4.03%
48 min ago
Summary
- As of February 7, 2025, AXSM EV/EBITDA is -16.67, with a rise of +0.70 (+4.03%) during the most recent trading day.
- Over the past year, AXSM EV/EBITDA has increased by +2.45 (+12.81%).
- AXSM EV/EBITDA is now -1182.31% below its all-time high of -1.30.
Performance
AXSM EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
AXSM EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +4.0% | -4.0% | -3.9% |
1 m1 month | -27.1% | +27.1% | +26.2% |
3 m3 months | -14.6% | +14.6% | +14.1% |
6 m6 months | -28.0% | +28.1% | +26.4% |
ytdytd | -25.5% | +25.5% | +24.7% |
1 y1 year | +12.8% | +15.8% | +11.1% |
5 y5 years | +64.2% | +59.3% | +17.4% |
AXSM EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -32.1% | -18.21 | +8.5% | |
3 m | 3-month | -12.62 | -32.1% | -18.21 | +8.5% |
6 m | 6-month | -12.39 | -34.5% | -18.21 | +8.5% |
1 y | 1-year | -10.56 | -57.9% | -19.65 | +15.2% |
3 y | 3-year | -6.06 | -175.1% | -27.29 | +38.9% |
5 y | 5-year | -6.06 | -175.1% | -48.23 | +65.4% |
alltime | all time | -1.30 | -1182.3% | -74.77 | +77.7% |
Axsome Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -16.67(+25.5%) |
2024 | -13.28(-16.4%) |
2023 | -15.88(-14.3%) |
2022 | -18.52(+64.3%) |
2021 | -11.27(-61.2%) |
Date | Value |
---|---|
2020 | -29.04(-46.2%) |
2019 | -53.94(+1966.7%) |
2018 | -2.61(-39.4%) |
2017 | -4.31(+13.7%) |
2016 | -3.79(-66.2%) |
2015 | -11.21 |
FAQ
- What is Axsome Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Axsome Therapeutics?
- What is AXSM EV/EBITDA year-to-date change?
- What is Axsome Therapeutics EV/EBITDA year-on-year change?
What is Axsome Therapeutics EV/EBITDA?
The current EV/EBITDA of AXSM is -16.67
What is the all time high EV/EBITDA for Axsome Therapeutics?
Axsome Therapeutics all-time high EV/EBITDA is -1.30
What is AXSM EV/EBITDA year-to-date change?
Axsome Therapeutics EV/EBITDA has changed by -3.39 (-25.53%) since the beginning of the year
What is Axsome Therapeutics EV/EBITDA year-on-year change?
Over the past year, AXSM EV/EBITDA has changed by +2.45 (+12.81%)